Bladder cancer: state-of-the-art care.
The challenge in bladder cancer is to control superficial disease and prevent its recurrence or progression. Patients with invasive disease need to be identified earlier, when disease may be less advanced and more amenable to cure. An important area for further investigation is the biology of the various forms of bladder cancer and the various pathways of development they may follow.
Droller
M J
MJ
Department of Urology, Mount Sinai Medical Center, New York, NY, USA.
D014408:Biomarkers, Tumor / Q000032:analysis; D003952:Diagnostic Imaging; D005260:Female; D006801:Humans; D008297:Male; D009361:Neoplasm Invasiveness; D009367:Neoplasm Staging; D011379:Prognosis; D001743:Urinary Bladder / Q000473:pathology; D001749:Urinary Bladder Neoplasms / Q000175:diagnosis / Q000209:etiology / Q000473:pathology / Q000628:therapy*
D014408:Biomarkers, Tumor